← Back to Patent Explorer
US5620971A Expired / Lapsed US ⏱️ 0.0 years remaining

Biologically active acylated amino acid derivatives

Assignee: Vertex Pharmaceuticals Inc
•
Filing: 1994-03-25
•
Granted: 1997-04-15
•
Expires: 2014-03-25
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention relates to novel compounds which possess a broad range of useful biological activities. These compounds can maintain, increase, or restore sensitivity of cells to therapeutic or prophylactic agents. They can also suppress, modify, or significantly reduce an immune response, including an autoimmune response in a mammal. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well-suited for treatment of multi-drug resistant cells, for prevention of the development of multi-drug resistance, for use in multi-drug resistant cancer therapy, and for prevention or treatment of graft rejection and various autoimmune diseases.

Inventors

  • 👤 David M. Armistead
  • 👤 Jeffrey O. Saunders
  • 👤 Joshua S. Boger

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 16:24
CPC Classifications
C; C07; C07D; C07D401/00; C07D401/02; C07D401/12; C07D207/00; C07D207/02; C07D207/04; C07D207/10; C07D207/16; C07D211/00; C07D211/04; C07D211/06; C07D211/36; C07D211/60; C07D401/14; C07D403/00; C07D403/02; C07D403/12; C07D405/00; C07D405/14; C07D409/00; C07D409/02; C07D409/12; C07D471/00; C07D471/02; C07D471/04; C07D473/00

Claims Analysis

Total Claims: 36
Claim 1
Independent Claim 374 words
A compound of formula (I): ##STR17## wherein: A is O, NH, or N--(C1-C4 alkyl); B and D are independently: (i) Ar 2 , (C5-C7)-cycloalkyl substituted (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl, (C5-C7)-cycloalkenyl substituted (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl, or Ar 2 -substituted (C1-C6)-straight or branched alkyl or Ar 2 -substituted (C2-C6)-straight or branched alkenyl, wherein in each case, any one of the CH 2 groups in said alkyl or alkenyl chains is optionally replaced by a heteroatom selected from the group consisting of O, S, SO, SO 2 ; or (ii) ##STR18## wherein Q is hydrogen, (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl; wherein T is Ar 2 or substituted 5-7 membered cycloalkyl with substituents at positions 3 and 4 which are independently selected from the group consisting of hydrogen, oxo, hydroxyl, O--(C1-C4-alkyl) and O--(C2-C4-alkenyl); wherein Ar 2 is selected from the group consisting of phenyl, 1-naphthyl, 2-naphthyl, 2-furyl, 3-furyl, 2-thienyl, 3-thienyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, and other monocyclic and bicyclic heterocyclic ring systems with individual ring sizes of 5 or 6 which may contain in either or both rings a total of 1 to 4 heteroatoms independently selected from oxygen, nitrogen and sulfur; wherein any occurrence of Ar 2 optionally contains one to three substituents which are independently selected from the group consisting of hydrogen, halogen, hydroxyl, hydroxymethyl, nitro, trifluoromethyl, trifluoromethoxy, (C1-C6)-straight or branched alkyl, (C2-C6)-straight or branched alkenyl, O-((C1-C4)-straight or branched alkyl), O--((C2-C4)-straight or branched alkenyl), O-benzyl, O-phenyl, 1,2-methylenedioxy, amino, carboxyl and phenyl; L is U; M is either oxygen or CH--U; provided that if L is hydrogen, then M is CH--U or if M is oxygen then L is not hydrogen; wherein U is hydrogen, O--((C1-C4)-straight or branched alkyl), O--((C2-C4)-straight or branched alkenyl), (C1-C6)-straight or branched alkyl, (C2-C6)-straight or branched alkenyl, (C5-C7)-cycloalkyl, (C5-C7)-cycloalkenyl substituted with (C1-C4)-straight or branched alkyl or (C2-C4)-straight or branched alkenyl, ((C1-C4)-alkyl or (C2-C4)-alkenyl)-Ar 2 or Ar 2 (Ar 2 as defined above); J and K are taken together with the N and C atom to which they are respectively attached to form a 5-7 membered heterocyclic ring containing only one N atom; m is 0-3; and the stereochemistry at carbon positions 1 and 2 are independently (R) or (S).
Claim 2
Dependent Claim 374 words
A compound of formula (I): ##STR17## wherein: A is O, NH, or N--(C1-C4 alkyl); B and D are independently: (i) Ar 2 , (C5-C7)-cycloalkyl substituted (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl, (C5-C7)-cycloalkenyl substituted (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl, or Ar 2 -substituted (C1-C6)-straight or branched alkyl or Ar 2 -substituted (C2-C6)-straight or branched alkenyl, wherein in each case, any one of the CH 2 groups in said alkyl or alkenyl chains is optionally replaced by a heteroatom selected from the group consisting of O, S, SO, SO 2 ; or (ii) ##STR18## wherein Q is hydrogen, (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl; wherein T is Ar 2 or substituted 5-7 membered cycloalkyl with substituents at positions 3 and 4 which are independently selected from the group consisting of hydrogen, oxo, hydroxyl, O--(C1-C4-alkyl) and O--(C2-C4-alkenyl); wherein Ar 2 is selected from the group consisting of phenyl, 1-naphthyl, 2-naphthyl, 2-furyl, 3-furyl, 2-thienyl, 3-thienyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, and other monocyclic and bicyclic heterocyclic ring systems with individual ring sizes of 5 or 6 which may contain in either or both rings a total of 1 to 4 heteroatoms independently selected from oxygen, nitrogen and sulfur; wherein any occurrence of Ar 2 optionally contains one to three substituents which are independently selected from the group consisting of hydrogen, halogen, hydroxyl, hydroxymethyl, nitro, trifluoromethyl, trifluoromethoxy, (C1-C6)-straight or branched alkyl, (C2-C6)-straight or branched alkenyl, O-((C1-C4)-straight or branched alkyl), O--((C2-C4)-straight or branched alkenyl), O-benzyl, O-phenyl, 1,2-methylenedioxy, amino, carboxyl and phenyl; L is U; M is either oxygen or CH--U; provided that if L is hydrogen, then M is CH--U or if M is oxygen then L is not hydrogen; wherein U is hydrogen, O--((C1-C4)-straight or branched alkyl), O--((C2-C4)-straight or branched alkenyl), (C1-C6)-straight or branched alkyl, (C2-C6)-straight or branched alkenyl, (C5-C7)-cycloalkyl, (C5-C7)-cycloalkenyl substituted with (C1-C4)-straight or branched alkyl or (C2-C4)-straight or branched alkenyl, ((C1-C4)-alkyl or (C2-C4)-alkenyl)-Ar 2 or Ar 2 (Ar 2 as defined above); J and K are taken together with the N and C atom to which they are respectively attached to form a 5-7 membered heterocyclic ring containing only one N atom; m is 0-3; and the stereochemistry at carbon positions 1 and 2 are independently (R) or (S).
Claim 3
Dependent Claim 574 words
A compound of formula (I): ##STR19## wherein: A is CH 2 , oxygen, NH or N--(C1-C4 alkyl); B and D are independently (i) Ar 1 , (C1-C10)-straight or branched alkyl, (C2-C10)-straight or branched alkenyl or alkynyl, (C5-C7)-cycloalkyl-substituted (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl or alkynyl, (C5-C7)-cycloalkenyl-substituted (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl or alkynyl, or Ar 1 -substituted (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl or alkynyl wherein, in each case, any one of the CH 2 groups of said alkyl, alkenyl or alkynyl chains is optionally replaced by a heteroatom selected from the group consisting of O, S, SO, SO 2 ; or (ii) ##STR20## wherein Q is hydrogen, (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl or alkynyl; wherein T is Ar 1 or substituted 5-7 membered cycloalkyl with substituents at positions 3 and 4 which are independently selected from the group consisting of oxo, hydrogen, hydroxyl, O--(C1-C4)-alkyl or O--(C2-C4)-alkenyl; provided that at least one of B or D is independently selected from the group consisting of (C2-C10)-straight or branched alkynyl, (C5-C7)-cycloalkyl-substituted (C2-C6)-straight or branched alkynyl, (C5-C7)-cycloalkenyl-substituted (C2-C6)-straight or branched alkynyl, and Ar 1 -substituted (C2-C6)-straight or branched alkynyl; wherein Ar 1 is a carboxylic aromatic group selected from the group consisting of phenyl, 1-naphthyl, 2-naphthyl, indenyl, azulenyl, fluorenyl, and anthracenyl; or a heterocyclic aromatic group selected from the group consisting of 2-furyl, 3-furyl, 2-thienyl, 3-thienyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, pyrrolyl, oxazolyl, thiazolyl, imidazolyl, pyrazolyl, 2-pyrazolinyl, pyrazolidinyl, isoxazolyl, isothiazolyl, 1,2,3-oxadiazolyl, 1,2,3-triazolyl, 1,3,4-thiadiazolyl, pyridazinyl, pyrimidinyl, pyrazinyl, 1,3,5-triazinyl, 1,3,5-trithianyl, indolizinyl, indolyl, isoindolyl, 3H-indolyl, indolinyl, benzo[b]furanyl, benzo[b]thiophenyl, 1H-indazolyl, benzimidazolyl, benzthiazolyl, purinyl, 4H-quinolizinyl, quinolinyl, isoquinolinyl, cinnolinyl, phthalazinyl, quinazolinyl, quinoxalinyl, 1,8-naphthyridinyl, pteridinyl, carbazolyl, acridinyl, phenazinyl, phenothiazinyl, and phenoxazinyl; wherein any occurrence of Ar 1 optionally contains one to three substituents which are independently selected from the group consisting of hydrogen, halogen, hydroxyl, hydroxymethyl, nitro, trifluoromethyl, trifluoromethoxy, (C1-C6)-straight or branched alkyl, (C2-C6)-straight or branched alkenyl, O--((C1-C4)-straight or branched alkyl), O--((C2-C4)-straight or branched alkenyl), O-benzyl, O-phenyl, 1,2-methylenedioxy, amino, carboxyl, N-((C1-C5)-straight or branched alkyl or (C2-C5)-straight or branched alkenyl) carboxamides, N,N-di-((C1-C5)-straight or branched alkyl or (C2-C5)-straight or branched alkenyl)carboxamides, N-morpholinocarboxamide, N-benzylcarboxamide, N-thiomorpholinocarboxamide, N-picolinoylcarboxamide, O--X, CH 2 --(CH 2 ) q --X, O--(CH 2 ) q --X, (CH 2 ) q --O--X, and CH═CH--X; wherein X is 4-methoxyphenyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, pyrazyl, quinolyl, 3,5-dimethylisoxazoyl, isoxazoyl, 2-methylthiazoyl, thiazoyl, 2-thienyl, 3-thienyl, or pyrimidyl; and q is 0-2; L is U; M is either oxygen or CH--U; provided that if L is hydrogen, then M is CH--U or if M is oxygen, then L is not hydrogen; wherein U is hydrogen, O--((C1-C4)-straight or branched alkyl) or O--((C2-C4)straight or branched alkenyl), (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl, (C5-C7)-cycloalkyl or (C5-C7)-cycloalkenyl substituted with (C1-C4)-straight or branched alkyl or (C2-C4)-straight or branched alkenyl, ((C1-C4)-alkyl or (C2-C4)-alkenyl)--Y or Y; wherein Y is a carboxylic aromatic group selected from the group consisting of phenyl, 1-naphthyl, 2-naphthyl, indenyl, azulenyl, fluorenyl, and anthracenyl; or a heterocyclic aromatic group as defined above; wherein Y optionally contains one to three substituents which are independently selected from the group consisting of hydrogen, halogen, hydroxyl, nitro, trifluoromethyl, trifluoromethoxy, (C1-C6)-straight or branched alkyl, (C1-C6)-straight or branched alkenyl, O--((C1-C4)-straight or branched alkyl), O--((C2-C4)-straight or branched alkenyl), O--benzyl, O-phenyl, 1,2-methylenedioxy, amino, and carboxyl; J and K are taken together with the N and C atom to which they are respectively attached to form a 5-7 membered heterocyclic ring containing only one N atom; and m is 0-3.
Claim 4
Dependent Claim 574 words
A compound of formula (I): ##STR19## wherein: A is CH 2 , oxygen, NH or N--(C1-C4 alkyl); B and D are independently (i) Ar 1 , (C1-C10)-straight or branched alkyl, (C2-C10)-straight or branched alkenyl or alkynyl, (C5-C7)-cycloalkyl-substituted (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl or alkynyl, (C5-C7)-cycloalkenyl-substituted (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl or alkynyl, or Ar 1 -substituted (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl or alkynyl wherein, in each case, any one of the CH 2 groups of said alkyl, alkenyl or alkynyl chains is optionally replaced by a heteroatom selected from the group consisting of O, S, SO, SO 2 ; or (ii) ##STR20## wherein Q is hydrogen, (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl or alkynyl; wherein T is Ar 1 or substituted 5-7 membered cycloalkyl with substituents at positions 3 and 4 which are independently selected from the group consisting of oxo, hydrogen, hydroxyl, O--(C1-C4)-alkyl or O--(C2-C4)-alkenyl; provided that at least one of B or D is independently selected from the group consisting of (C2-C10)-straight or branched alkynyl, (C5-C7)-cycloalkyl-substituted (C2-C6)-straight or branched alkynyl, (C5-C7)-cycloalkenyl-substituted (C2-C6)-straight or branched alkynyl, and Ar 1 -substituted (C2-C6)-straight or branched alkynyl; wherein Ar 1 is a carboxylic aromatic group selected from the group consisting of phenyl, 1-naphthyl, 2-naphthyl, indenyl, azulenyl, fluorenyl, and anthracenyl; or a heterocyclic aromatic group selected from the group consisting of 2-furyl, 3-furyl, 2-thienyl, 3-thienyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, pyrrolyl, oxazolyl, thiazolyl, imidazolyl, pyrazolyl, 2-pyrazolinyl, pyrazolidinyl, isoxazolyl, isothiazolyl, 1,2,3-oxadiazolyl, 1,2,3-triazolyl, 1,3,4-thiadiazolyl, pyridazinyl, pyrimidinyl, pyrazinyl, 1,3,5-triazinyl, 1,3,5-trithianyl, indolizinyl, indolyl, isoindolyl, 3H-indolyl, indolinyl, benzo[b]furanyl, benzo[b]thiophenyl, 1H-indazolyl, benzimidazolyl, benzthiazolyl, purinyl, 4H-quinolizinyl, quinolinyl, isoquinolinyl, cinnolinyl, phthalazinyl, quinazolinyl, quinoxalinyl, 1,8-naphthyridinyl, pteridinyl, carbazolyl, acridinyl, phenazinyl, phenothiazinyl, and phenoxazinyl; wherein any occurrence of Ar 1 optionally contains one to three substituents which are independently selected from the group consisting of hydrogen, halogen, hydroxyl, hydroxymethyl, nitro, trifluoromethyl, trifluoromethoxy, (C1-C6)-straight or branched alkyl, (C2-C6)-straight or branched alkenyl, O--((C1-C4)-straight or branched alkyl), O--((C2-C4)-straight or branched alkenyl), O-benzyl, O-phenyl, 1,2-methylenedioxy, amino, carboxyl, N-((C1-C5)-straight or branched alkyl or (C2-C5)-straight or branched alkenyl) carboxamides, N,N-di-((C1-C5)-straight or branched alkyl or (C2-C5)-straight or branched alkenyl)carboxamides, N-morpholinocarboxamide, N-benzylcarboxamide, N-thiomorpholinocarboxamide, N-picolinoylcarboxamide, O--X, CH 2 --(CH 2 ) q --X, O--(CH 2 ) q --X, (CH 2 ) q --O--X, and CH═CH--X; wherein X is 4-methoxyphenyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, pyrazyl, quinolyl, 3,5-dimethylisoxazoyl, isoxazoyl, 2-methylthiazoyl, thiazoyl, 2-thienyl, 3-thienyl, or pyrimidyl; and q is 0-2; L is U; M is either oxygen or CH--U; provided that if L is hydrogen, then M is CH--U or if M is oxygen, then L is not hydrogen; wherein U is hydrogen, O--((C1-C4)-straight or branched alkyl) or O--((C2-C4)straight or branched alkenyl), (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl, (C5-C7)-cycloalkyl or (C5-C7)-cycloalkenyl substituted with (C1-C4)-straight or branched alkyl or (C2-C4)-straight or branched alkenyl, ((C1-C4)-alkyl or (C2-C4)-alkenyl)--Y or Y; wherein Y is a carboxylic aromatic group selected from the group consisting of phenyl, 1-naphthyl, 2-naphthyl, indenyl, azulenyl, fluorenyl, and anthracenyl; or a heterocyclic aromatic group as defined above; wherein Y optionally contains one to three substituents which are independently selected from the group consisting of hydrogen, halogen, hydroxyl, nitro, trifluoromethyl, trifluoromethoxy, (C1-C6)-straight or branched alkyl, (C1-C6)-straight or branched alkenyl, O--((C1-C4)-straight or branched alkyl), O--((C2-C4)-straight or branched alkenyl), O--benzyl, O-phenyl, 1,2-methylenedioxy, amino, and carboxyl; J and K are taken together with the N and C atom to which they are respectively attached to form a 5-7 membered heterocyclic ring containing only one N atom; and m is 0-3.
Claim 5
Dependent Claim 83 words
The compound according to claim 2, wherein said Ar 1 group contains one to three substituents selected from the group consisting of N-((C1-C5)-straight or branched alkyl or (C2-C5)-straight or branched alkenyl) carboxamides, N,N-di-((C1-C5)-straight or branched alkyl or alkenyl)carboxamides, N-morpholinocarboxamide, N-benzylcarboxamide, N-thiomorpholinocarboxamide, N-picolinoylcarboxamide, O--X, CH 2 --(CH 2 ) q --X, O--(CH 2 ) q --X, (CH 2 ) q --O--X, and CH═CH--X; wherein X is 4-methoxyphenyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, pyrazyl, quinolyl, 3,5-dimethylisoxazoyl, isoxazoyl, 2-methylthiazoyl, thiazoyl, 2-thienyl, 3-thienyl, or pyrimidyl, and q is 0-2.
Claim 6
Dependent Claim 31 words
The compound according to any one of claims 1-3, wherein in formula (I), M is O and J and K are taken together to form a pyrrolidine or a piperidine ring.
Claim 7
Dependent Claim 76 words
The compound according to claim 4, wherein in formula (I), B is selected from the group consisting of 3-(2-pyridyl)propyl, 3-phenylpropyl, 2-phenoxypropyl, phenyl, 2(3-pyridyl)ethyl, E-2-[trans-(4-hydroxycyclohexyl)]-1-methyl-ethenyl, 3-(3-pyridyl)propyl, benzyl, 2-phenylethyl, 2-(4-methoxyphenyl)ethyl, 3-(N-benzimidazolyl)propyl, 3-(4-methoxyphenyl)propyl, 3-[N-(7-azaindolyl)]propyl, 3-(N-purinyl)propyl, 3-(3-pyridyl)propyl-N-oxide, 3-(4-hydroxymethylphenyl) propyl, 3-(2-thienyl)propyl, 3-(4-carboxyphenyl)propyl, 4-phenylbutyl, 2-hydroxymethyl-phenyl, 2-allyloxyphenyl, 3-(3-hydroxymethylphenyl, 2-hydroxyphenyl, 3-pyridyl and 5-phenylpentyl; D is selected from the group consisting of 3-phenylpropyl, 2-phenoxyphenyl, 3-(3-indolyl)propyl, 2-phenylethyl, 4-phenylbutyl, and 3-(4-methoxyphenyl)propyl; and L is selected from the group consisting of 3,4,5-trimethoxyphenyl, phenyl, tert-butyl, 3-benzyloxy-phenyl, 3-allyloxyphenyl and 3-isopropoxyphenyl.
Claim 8
Dependent Claim 275 words
A compound of formula (II): ##STR21## wherein n, m, B, D and U are defined as follows: ______________________________________ n m B D U ______________________________________ 1 0 3-(Pyridin-2- 3-Phenylpropyl 3,4,5-Trimethoxyphenyl yl)propyl 2 0 3-Phenyl- 3-Phenylpropyl 3,4,5-Trimethoxyphenyl propyl 2 0 2-Phenoxy- 3-Phenylpropyl 3,4,5-Trimethoxyphenyl phenyl 2 0 Phenyl 2-Phenoxy- 3,4,5-Trimethoxyphenyl phenyl 2 0 Phenyl 3-Phenylpropyl 3,4,5-Trimethoxyphenyl 2 0 2-(Pyridin-3- 3-Phenylpropyl 3,4,5-Trimethoxyphenyl yl)ethyl 2 0 E-3-[trans-(4- 3-Phenylpropyl 3,4,5-Trimethoxyphenyl Hydroxy- cyclohexyl)]- 2-methyl-eth- 2-enyl 2 0 3-(Pyridin-3- 3-Phenylpropyl 3,4,5-Trimethoxyphenyl yl)propyl 2 0 Benzyl 3-Phenylpropyl 3,4,5-Trimethoxyphenyl 2 0 Benzyl 3-(Indol-3-yl) 3,4,5-Trimethoxyphenyl propyl 2 0 2-Phenylethyl 3-Phenylpropyl 3,4,5-Trimethoxyphenyl 2 0 2-(4-Methoxy- 3-Phenylpropyl 3,4,5-Trimethoxyphenyl phenyl)ethyl 2 0 2-(4-Methoxy- 3-Phenylpropyl Phenyl phenyl)ethyl 2 0 3-(N- 3-Phenylpropyl 3,4,5-Trimethoxyphenyl Benzimida- zolyl)propyl 2 1 Benzyl 2-Phenylethyl 3,4,5-Trimethoxyphenyl 2 0 3-(4-Methoxy- 3-Phenylpropyl 3,4,5-Trimethoxyphenyl phenyl) propyl 2 0 3-(Pyridin-3- 3-Phenylpropyl Phenyl yl)-propyl 2 0 3-(Pyridin-2- 3-Phenylpropyl Phenyl yl)-propyl 2 0 3-(Pyridin-2- 3-Phenylpropyl 3,4,5-Trimethoxyphenyl yl)-propyl 2 0 3-(Pyridin- 3-Phenylpropyl tert-Butyl 2yl)-propyl 2 0 3-(Pyridin-3- 3-Phenylpropyl 3,4,5-Trimethoxyphenyl yl)-propyl N-oxide 2 0 3-IN-(7- 3-Phenylpropyl 3,4,5-Trimethoxyphenyl Azaindolyl)- propyl 2 0 3-(Pyridin- 3-(4-Methoxy- 3,4,5-Trimethoxyphenyl 3-yl)-propyl phenyl)propyl 2 0 3-(N-Purinyl) 3-Phenylpropyl 3,4,5-Trimethoxyphenyl propyl 2 0 3-(4-Hydroxy- 3-Phenylpropyl 3,4,5-Trimethoxyphenyl methyl- phenyl) propyl 2 0 3-(Pyridin-3- 3-Phenylpropyl 3-Benzyloxyphenyl yl)-propyl 2 0 3-(Pyridin-3- 3-Phenylpropyl 3-Allyloxyphenyl yl)-propyl 2 0 3-(Pyridin-3- 3-Phenylpropyl 3-Isopropoxyphenyl yl)-propyl 2 0 3-(Thiophen- 3-Phenylpropyl 3,4,5-Trimethoxyphenyl 2-yl)-propyl 2 0 3-(4-Carboxy- 3-Phenylpropyl 3,4,5-Trimethoxyphenyl phenyl) propyl 2 0 3-Phenylbutyl 3-Phenylpropyl 3,4,5-Trimethoxyphenyl 2 0 2-Hydroxy- 3-Phenylpropyl 3,4,6-Trimethoxyphenyl methyl- phenyl 2 0 2-Allyloxy- 3-Phenylpropyl 3,4,5-Trimethoxyphenyl phenyl 2 0 3-(3-Hydroxy- 3-Phenylpropyl 3,4,5-Trimethoxyphenyl methyl- phenyl) propyl 2 0 3-(3-Carboxy- 3-Phenylpropyl 3,4,5-Trimethoxyphenyl phenyl) propyl 2 0 3-Hydroxy- 3-Phenylpropyl 3,4,5-Trimethoxyphenyl methyl- phenyl 2 0 2-Hydroxy- 3-Phenylpropyl 3,4,5-Trimethoxyphenyl phenyl 2 0 Pyridin-3-yl 3-Phenylpropyl 3,4,5-Trimethoxyphenyl 2 0 3-(Thiophen- 4-Phenylbutyl 3,4,5-Trimethoxyphenyl 2-yl)-propyl 2 0 5-Phenyl- 3-Phenylpropyl 3,4,5-Trimethoxyphenyl pentyl ______________________________________
Claim 9
Dependent Claim 275 words
A compound of formula (II): ##STR21## wherein n, m, B, D and U are defined as follows: ______________________________________ n m B D U ______________________________________ 1 0 3-(Pyridin-2- 3-Phenylpropyl 3,4,5-Trimethoxyphenyl yl)propyl 2 0 3-Phenyl- 3-Phenylpropyl 3,4,5-Trimethoxyphenyl propyl 2 0 2-Phenoxy- 3-Phenylpropyl 3,4,5-Trimethoxyphenyl phenyl 2 0 Phenyl 2-Phenoxy- 3,4,5-Trimethoxyphenyl phenyl 2 0 Phenyl 3-Phenylpropyl 3,4,5-Trimethoxyphenyl 2 0 2-(Pyridin-3- 3-Phenylpropyl 3,4,5-Trimethoxyphenyl yl)ethyl 2 0 E-3-[trans-(4- 3-Phenylpropyl 3,4,5-Trimethoxyphenyl Hydroxy- cyclohexyl)]- 2-methyl-eth- 2-enyl 2 0 3-(Pyridin-3- 3-Phenylpropyl 3,4,5-Trimethoxyphenyl yl)propyl 2 0 Benzyl 3-Phenylpropyl 3,4,5-Trimethoxyphenyl 2 0 Benzyl 3-(Indol-3-yl) 3,4,5-Trimethoxyphenyl propyl 2 0 2-Phenylethyl 3-Phenylpropyl 3,4,5-Trimethoxyphenyl 2 0 2-(4-Methoxy- 3-Phenylpropyl 3,4,5-Trimethoxyphenyl phenyl)ethyl 2 0 2-(4-Methoxy- 3-Phenylpropyl Phenyl phenyl)ethyl 2 0 3-(N- 3-Phenylpropyl 3,4,5-Trimethoxyphenyl Benzimida- zolyl)propyl 2 1 Benzyl 2-Phenylethyl 3,4,5-Trimethoxyphenyl 2 0 3-(4-Methoxy- 3-Phenylpropyl 3,4,5-Trimethoxyphenyl phenyl) propyl 2 0 3-(Pyridin-3- 3-Phenylpropyl Phenyl yl)-propyl 2 0 3-(Pyridin-2- 3-Phenylpropyl Phenyl yl)-propyl 2 0 3-(Pyridin-2- 3-Phenylpropyl 3,4,5-Trimethoxyphenyl yl)-propyl 2 0 3-(Pyridin- 3-Phenylpropyl tert-Butyl 2yl)-propyl 2 0 3-(Pyridin-3- 3-Phenylpropyl 3,4,5-Trimethoxyphenyl yl)-propyl N-oxide 2 0 3-IN-(7- 3-Phenylpropyl 3,4,5-Trimethoxyphenyl Azaindolyl)- propyl 2 0 3-(Pyridin- 3-(4-Methoxy- 3,4,5-Trimethoxyphenyl 3-yl)-propyl phenyl)propyl 2 0 3-(N-Purinyl) 3-Phenylpropyl 3,4,5-Trimethoxyphenyl propyl 2 0 3-(4-Hydroxy- 3-Phenylpropyl 3,4,5-Trimethoxyphenyl methyl- phenyl) propyl 2 0 3-(Pyridin-3- 3-Phenylpropyl 3-Benzyloxyphenyl yl)-propyl 2 0 3-(Pyridin-3- 3-Phenylpropyl 3-Allyloxyphenyl yl)-propyl 2 0 3-(Pyridin-3- 3-Phenylpropyl 3-Isopropoxyphenyl yl)-propyl 2 0 3-(Thiophen- 3-Phenylpropyl 3,4,5-Trimethoxyphenyl 2-yl)-propyl 2 0 3-(4-Carboxy- 3-Phenylpropyl 3,4,5-Trimethoxyphenyl phenyl) propyl 2 0 3-Phenylbutyl 3-Phenylpropyl 3,4,5-Trimethoxyphenyl 2 0 2-Hydroxy- 3-Phenylpropyl 3,4,6-Trimethoxyphenyl methyl- phenyl 2 0 2-Allyloxy- 3-Phenylpropyl 3,4,5-Trimethoxyphenyl phenyl 2 0 3-(3-Hydroxy- 3-Phenylpropyl 3,4,5-Trimethoxyphenyl methyl- phenyl) propyl 2 0 3-(3-Carboxy- 3-Phenylpropyl 3,4,5-Trimethoxyphenyl phenyl) propyl 2 0 3-Hydroxy- 3-Phenylpropyl 3,4,5-Trimethoxyphenyl methyl- phenyl 2 0 2-Hydroxy- 3-Phenylpropyl 3,4,5-Trimethoxyphenyl phenyl 2 0 Pyridin-3-yl 3-Phenylpropyl 3,4,5-Trimethoxyphenyl 2 0 3-(Thiophen- 4-Phenylbutyl 3,4,5-Trimethoxyphenyl 2-yl)-propyl 2 0 5-Phenyl- 3-Phenylpropyl 3,4,5-Trimethoxyphenyl pentyl ______________________________________
Claim 10
Dependent Claim 594 words
A compound of formula (II): ##STR22## wherein n, m, B, D and U are defined as follows: ______________________________________ n m B D U ______________________________________ 2 0 3-Allyloxypropyl 3-Phenylpropyl 3,4,5-Tri- methoxyphenol 2 0 3-[4-(N,N-Di 3-Phenylpropyl 3,4,5-Tri- methylamine- methoxyphenol carbonyl)-phenyl] propyl 2 0 3-14-(Morpholino- 3-Phenylpropyl 3,4,5-Tri- 4-carbonyl) methoxyphenol phenyl)-propyl 2 0 4-Allyoxybutyl 3-Phenylpropyl 3,4,5-Tri- methoxyphenol 2 0 3-Allyloxy- 3-Phenylpropyl 3,4,5-Tri- prop-1-ynyl methoxyphenol 2 0 3[4-(Piperi- 3-Phenylpropyl 3,4,5-Tri- dine-1-carbonyl) methoxyphenol phenyl)-propyl 2 0 5-Allyloxynonyl 3-Phenylpropyl 3,4,5-Tri- methoxyphenol 2 0 Methyl 3,5-Bis(benzyl- 3,4,5-Tri- oxy)phenyl methoxyphenol 2 0 2-Allyloxyethyl 3-Phenylpropyl 3,4,5-Tri- methoxyphenol 2 0 3-Allyloxy-(E)- 3-Phenylpropyl 3,4,5-Tri- prop-l-onyl methoxyphenol 2 0 3-13-(Morpho- 3-Phenylpropyl 3,4,5-Tri- lino-4-carbonyl) methoxyphenol phenyl]propyl 2 0 Dec-9-enyl 3-Phenylpropyl 3,4,5-Tri- methoxyphenol 2 0 3-[4-(N-Benzyl 3-Phenylpropyl 3,4,5-Tri- aminecarbonyl)- methoxyphenol phenyl]propyl 2 0 3-[4-(Thiomorpho- 3-Phenylpropyl 3,4,5-Tri- lino-4-carbonyl)- methoxyphenol phenyl]propyl 2 0 3-(Morpholino-4- 3-Phenylpropyl 3,4,5-Tri- carbonyl)phenyl- methoxyphenol 2 0 3-[4-(1-Methyl- 3-Phenylpropyl 3,4,5-Tri- piperazine-4- methoxyphenol carbonyl)-phenyl] propyl 2 0 3-[4-(1-Benzyl- 3-Phenylpropyl 3,4,5-Tri- piperazine-4- methoxyphenol carbonyl)-phenyl] propyl 2 0 3-[3-(N-Benzyl- 3-Phenylpropyl 3,4,5-Tri- aminecarbonyl)- methoxyphenol phenylpropyl 2 0 3-[4-(N-Pyridin- 3-Phenylpropyl 3,4,5-Tri- 2-ylaminecarbon- methoxyphenol yl)-phenyl]propyl 2 0 Pryidin-3-yl 3-(Pyridin-3-yl)- 3,4,5-Tri- propyl methoxyphenol 2 0 Prop-2-enyl 3,4-Bis-(Pyridin-4- 3,4,5-Tri- ylmethoxy)phenyl methoxyphenol 2 0 Pyridin-3-yl 3-(Pyridin-4-yl- 3,4,5-Tri- methoxy)phenyl methoxyphenol 2 0 3-Phenylpropyl 3-(Pyridin-4-yl- 3,4,5-Tri- methoxy)phenyl methoxyphenol 2 0 3-Phenylpropyl 3,4-Bis-(Pyridin-4- 3,4,5-Tri- ylmethoxy)phenyl methoxyphenol 2 0 Methyl 3,4-Bis-(Pyridin-4- 3,4,5-Tri- ylmethoxy)phenyl methoxyphenol 2 0 3-Phenylpropyl 2,3,4-Tris-(Pyridin- 3,4,5-Tri- 4-ylmethoxy)phenyl methoxyphenol 2 0 3-Phenylpropyl 3-(Morpholino-4- 3,4,5-Tri- carbonyl)-4- methoxyphenol (Pyridin-4-yl- methoxy)phenyl 2 0 Methyl 3,4,5-Tris-(Pyridin- 3,4,5-Tri- 4-ylmethoxy)phenyl methoxyphenol 2 0 3-Phenylpropyl 3,4,5-Tris-(Pyridin- 3,4,5-Tri- 4-ylmethoxy)phenyl methoxyphenol 2 0 Methyl 3,5-Bis-(Pyridin-4- 3,4,5-Tri- ylmethoxy)phenyl methoxyphenol 2 0 3,5-Bis-(Pyridin- Methyl 3,4,5-Tri- 4-ylmethoxy) methoxyphenol phenyl 2 0 Methyl 3,5-Bis-(Pyridin-4- 3,4,5-Tri- y[methoxy)-4- methoxyphenol Methyl-phenyl 2 0 Ethyl 3,4,5-Tris-(Pyridin- 3,4,5-Tri- 4-ylmethoxy)phenyl methoxyphenol 2 0 3,4,5-Tris- Ethyl 3,4,5-Tri- (Pyridin-4-yl- methoxyphenol methoxy)phenyl 2 0 Prop-2-enyl 3,4,5-Tris-(Pyridin- 3,4,5-Tri- 4-ylmethoxy)phenyl methoxyphenol 2 0 Methyl 3,4,6-Tris-(Pyridin- 3,4-Di- 4-ylmethoxy)phenyl methoxyphenyl 2 0 Ethenyl 3,4,5-Tris-(Pyridin- 3,4,5-Tri- 4-ylmethoxy)phenyl methoxyphenol 2 0 3,4,5-Tris- Ethenyl 3,4,5-Tri- (Pyridin-4- methoxyphenol ylmethoxy)phenyl 2 0 Propyl 3,4,5-Tris-(Pyridin- 3,4,5-Tri- 4-ylmethoxy)phenyl methoxyphenol 2 0 3,4,5-Tris- Propyl 3,4,5-Tri- (Pyridin-4- methoxyphenol ylmethoxy)phenyl 2 0 Methyl 3,4,5-Tris- 3,4,5-Tri- (Thiophen-3-yl- methoxyphenol methoxy)phenyl 2 0 3,4,5-Tris- Methyl 3,4,5-Tri- (Thio-phen-3- methoxyphenol ylmethoxy)- phenyl 2 0 Methyl 2-isopropoxy-3,4- 3,4,5-Tri- Bis-(Pyridin-4- methoxyphenol ylmethoxy)-phenyl 2 0 2-Isopropoxy- Methyl 3,4,5-Tri- 3,4-Bis-(Pyridin- methoxyphenol 4-yl-methoxy) phenyl 1 0 Methyl 3,4,5-Tris-(Pyridin- 3,4,5-Tri- 4-ylmethoxy)phenyl methoxyphenol 1 0 3,4,5-Tris- Methyl 3,4,5-Tri- (Pyridin-4- methoxyphenol ylmethoxy)phenyl 2 0 Methyl 3,4,5-Tris- 3,4,5-Tri- (Pyrimidin-4- methoxyphenol ylmethoxy)phenyl 2 0 Benzyloxymethyl Benzyloxyphenyl 3,4,5-Tri- methoxyphenol 2 0 Methyl 3,4,5-Tris-(Benzyl- 3,4,5-Tri- oxy)phenyl methoxyphenol 2 0 3-Phenylpropyl 3-(Pyridin-3-yl- 3,4,5-Tri- carbonyl)phenyl methoxyphenol 2 0 3-(Pyridin-3-yl- 3-Phenylpropyl 3,4,5-Tri- carbonyl)phenyl methoxyphenol 2 0 3-Phenylpropyl 3-(Pyridin-4-yl- 3,4-Di- methoxy)phenyl methoxyphenol 2 0 3-Phenylpropyl 3-(Pyridin-4-yl- 4-Benzyloxy- carbonyl)phenyl 3,5-Dimethoxy- phenyl 2 0 3-Phenylpropyl 3-(Pyridin-4-yl- 4-Allylyoxy-3,5- carbonyl)phenyl Dimethoxy- phenyl 2 0 3-Phenylpropyl 3-(Pyridin-4-yl- 3-Benzyloxy-4- carbonyl)phenyl methoxyphenyl 2 0 3-Phenylpropyl 3-(Pyridin-4-yl- 3-Allyloxy-4- carbonyl)phenyl methoxyphenyl 2 0 3-Phenylpropyl 3-(Pyridin-4-yl- 3-[3-Phenyl-(E)- carbonyl)phenyl prop-2-enyl]-4- methoxyphenyl 2 0 3-Phenylpropyl 4-(Pyridin-4-yl- 4-Benzyloxy- carbonyl)phenyl 3,5-Dimethoxy- phenyl 2 0 3-Phenylpropyl 4-(Pyridin-4-yl- 3-Benzyloxy-4- carbonyl)phenyl methoxyphenyl 2 0 3-Phenylpropyl 3-(Pyridin-4-yl- 3,4,5-Tri- carbonyl)phenyl methoxyphenol 2 0 3-Phenylpropyl 3-(Pyridin-4-yl- 3,4-Di- carbonyl)phenyl methoxyphenyl 2 0 3-Phenylpropyl Phenyl 3-Benzyloxy-4- methoxyphenyl 2 0 3-Phenylpropyl Phenyl 4-Benzyloxy- 3,5-Dimethoxy- phenyl 1 0 3-(Pyridin-3- 3-Phenylpropyl tert-Butyl yl)-propyl 2 0 3-(Pyridin-3- 3-(Pyridin-3-yl)- 3,4,5-Tri- yl)-propyl propyl methoxyphenol 1 0 Benzyloxymethyl Benzyloxyphenyl 3,4,5-Tri- methoxyphenol 1 0 3-(Pyridin-3- 3-(Pyridin-3-yl)- 3,4,5-Tri- yl-propyl propyl methoxyphenol 2 0 3-(Pyridin-3- 3-(Pyridin-3-yl)- Isopropyl yl)-propyl propyl 2 0 3-(Pyridin-3- 3-(Pyridin-3-yl)- Thiophen-2-yl yl)- 2 0 3-(Pyridin-3- 3-(Pyridin-3-yl)- 3,4-Methylene- yl)-propyl propyl dioxyphenyl 2 0 3-(Pyridin-3- 3-(Pyridin-3-yl)- 3,4-Methylene- yl)-prop-2-ynyl prop-2-ynyl dioxyphenyl 2 0 3-(Pyridin-3- 3-(Pyridin-3-yl)- 3,4,5-Tri- yl)-prop-2-ynyl prop-2-ynyl methoxyphenol 2 0 3-(Pyridin-2- 3-(Pyridin-2-yl)- 3,4,5-Tri- yl-propyl propyl methoxyphenol 2 0 Isopropyl 3,4,5-Tris-(Pyridin- 3,4,5-Tri- 4-ylmethoxy)phenyl methoxyphenol 2 0 3,4,5-Tris- Isopropyl 3,4,5-Tri- (Pyridin-4- methoxyphenol ylmethoxy)phenyl 2 0 Prop-2-enyl 3,4,5-Tris-(Pyridin- 3,4,5-Tri- 4-ylmethoxy)phenyl methoxyphenol 2 0 3,4,5-Tris- Prop-2-enyl 3,4,5-Tri- (Pyridin-4- methoxyphenol ylmethoxy)phenyl ______________________________________
Claim 11
Dependent Claim 594 words
A compound of formula (II): ##STR22## wherein n, m, B, D and U are defined as follows: ______________________________________ n m B D U ______________________________________ 2 0 3-Allyloxypropyl 3-Phenylpropyl 3,4,5-Tri- methoxyphenol 2 0 3-[4-(N,N-Di 3-Phenylpropyl 3,4,5-Tri- methylamine- methoxyphenol carbonyl)-phenyl] propyl 2 0 3-14-(Morpholino- 3-Phenylpropyl 3,4,5-Tri- 4-carbonyl) methoxyphenol phenyl)-propyl 2 0 4-Allyoxybutyl 3-Phenylpropyl 3,4,5-Tri- methoxyphenol 2 0 3-Allyloxy- 3-Phenylpropyl 3,4,5-Tri- prop-1-ynyl methoxyphenol 2 0 3[4-(Piperi- 3-Phenylpropyl 3,4,5-Tri- dine-1-carbonyl) methoxyphenol phenyl)-propyl 2 0 5-Allyloxynonyl 3-Phenylpropyl 3,4,5-Tri- methoxyphenol 2 0 Methyl 3,5-Bis(benzyl- 3,4,5-Tri- oxy)phenyl methoxyphenol 2 0 2-Allyloxyethyl 3-Phenylpropyl 3,4,5-Tri- methoxyphenol 2 0 3-Allyloxy-(E)- 3-Phenylpropyl 3,4,5-Tri- prop-l-onyl methoxyphenol 2 0 3-13-(Morpho- 3-Phenylpropyl 3,4,5-Tri- lino-4-carbonyl) methoxyphenol phenyl]propyl 2 0 Dec-9-enyl 3-Phenylpropyl 3,4,5-Tri- methoxyphenol 2 0 3-[4-(N-Benzyl 3-Phenylpropyl 3,4,5-Tri- aminecarbonyl)- methoxyphenol phenyl]propyl 2 0 3-[4-(Thiomorpho- 3-Phenylpropyl 3,4,5-Tri- lino-4-carbonyl)- methoxyphenol phenyl]propyl 2 0 3-(Morpholino-4- 3-Phenylpropyl 3,4,5-Tri- carbonyl)phenyl- methoxyphenol 2 0 3-[4-(1-Methyl- 3-Phenylpropyl 3,4,5-Tri- piperazine-4- methoxyphenol carbonyl)-phenyl] propyl 2 0 3-[4-(1-Benzyl- 3-Phenylpropyl 3,4,5-Tri- piperazine-4- methoxyphenol carbonyl)-phenyl] propyl 2 0 3-[3-(N-Benzyl- 3-Phenylpropyl 3,4,5-Tri- aminecarbonyl)- methoxyphenol phenylpropyl 2 0 3-[4-(N-Pyridin- 3-Phenylpropyl 3,4,5-Tri- 2-ylaminecarbon- methoxyphenol yl)-phenyl]propyl 2 0 Pryidin-3-yl 3-(Pyridin-3-yl)- 3,4,5-Tri- propyl methoxyphenol 2 0 Prop-2-enyl 3,4-Bis-(Pyridin-4- 3,4,5-Tri- ylmethoxy)phenyl methoxyphenol 2 0 Pyridin-3-yl 3-(Pyridin-4-yl- 3,4,5-Tri- methoxy)phenyl methoxyphenol 2 0 3-Phenylpropyl 3-(Pyridin-4-yl- 3,4,5-Tri- methoxy)phenyl methoxyphenol 2 0 3-Phenylpropyl 3,4-Bis-(Pyridin-4- 3,4,5-Tri- ylmethoxy)phenyl methoxyphenol 2 0 Methyl 3,4-Bis-(Pyridin-4- 3,4,5-Tri- ylmethoxy)phenyl methoxyphenol 2 0 3-Phenylpropyl 2,3,4-Tris-(Pyridin- 3,4,5-Tri- 4-ylmethoxy)phenyl methoxyphenol 2 0 3-Phenylpropyl 3-(Morpholino-4- 3,4,5-Tri- carbonyl)-4- methoxyphenol (Pyridin-4-yl- methoxy)phenyl 2 0 Methyl 3,4,5-Tris-(Pyridin- 3,4,5-Tri- 4-ylmethoxy)phenyl methoxyphenol 2 0 3-Phenylpropyl 3,4,5-Tris-(Pyridin- 3,4,5-Tri- 4-ylmethoxy)phenyl methoxyphenol 2 0 Methyl 3,5-Bis-(Pyridin-4- 3,4,5-Tri- ylmethoxy)phenyl methoxyphenol 2 0 3,5-Bis-(Pyridin- Methyl 3,4,5-Tri- 4-ylmethoxy) methoxyphenol phenyl 2 0 Methyl 3,5-Bis-(Pyridin-4- 3,4,5-Tri- y[methoxy)-4- methoxyphenol Methyl-phenyl 2 0 Ethyl 3,4,5-Tris-(Pyridin- 3,4,5-Tri- 4-ylmethoxy)phenyl methoxyphenol 2 0 3,4,5-Tris- Ethyl 3,4,5-Tri- (Pyridin-4-yl- methoxyphenol methoxy)phenyl 2 0 Prop-2-enyl 3,4,5-Tris-(Pyridin- 3,4,5-Tri- 4-ylmethoxy)phenyl methoxyphenol 2 0 Methyl 3,4,6-Tris-(Pyridin- 3,4-Di- 4-ylmethoxy)phenyl methoxyphenyl 2 0 Ethenyl 3,4,5-Tris-(Pyridin- 3,4,5-Tri- 4-ylmethoxy)phenyl methoxyphenol 2 0 3,4,5-Tris- Ethenyl 3,4,5-Tri- (Pyridin-4- methoxyphenol ylmethoxy)phenyl 2 0 Propyl 3,4,5-Tris-(Pyridin- 3,4,5-Tri- 4-ylmethoxy)phenyl methoxyphenol 2 0 3,4,5-Tris- Propyl 3,4,5-Tri- (Pyridin-4- methoxyphenol ylmethoxy)phenyl 2 0 Methyl 3,4,5-Tris- 3,4,5-Tri- (Thiophen-3-yl- methoxyphenol methoxy)phenyl 2 0 3,4,5-Tris- Methyl 3,4,5-Tri- (Thio-phen-3- methoxyphenol ylmethoxy)- phenyl 2 0 Methyl 2-isopropoxy-3,4- 3,4,5-Tri- Bis-(Pyridin-4- methoxyphenol ylmethoxy)-phenyl 2 0 2-Isopropoxy- Methyl 3,4,5-Tri- 3,4-Bis-(Pyridin- methoxyphenol 4-yl-methoxy) phenyl 1 0 Methyl 3,4,5-Tris-(Pyridin- 3,4,5-Tri- 4-ylmethoxy)phenyl methoxyphenol 1 0 3,4,5-Tris- Methyl 3,4,5-Tri- (Pyridin-4- methoxyphenol ylmethoxy)phenyl 2 0 Methyl 3,4,5-Tris- 3,4,5-Tri- (Pyrimidin-4- methoxyphenol ylmethoxy)phenyl 2 0 Benzyloxymethyl Benzyloxyphenyl 3,4,5-Tri- methoxyphenol 2 0 Methyl 3,4,5-Tris-(Benzyl- 3,4,5-Tri- oxy)phenyl methoxyphenol 2 0 3-Phenylpropyl 3-(Pyridin-3-yl- 3,4,5-Tri- carbonyl)phenyl methoxyphenol 2 0 3-(Pyridin-3-yl- 3-Phenylpropyl 3,4,5-Tri- carbonyl)phenyl methoxyphenol 2 0 3-Phenylpropyl 3-(Pyridin-4-yl- 3,4-Di- methoxy)phenyl methoxyphenol 2 0 3-Phenylpropyl 3-(Pyridin-4-yl- 4-Benzyloxy- carbonyl)phenyl 3,5-Dimethoxy- phenyl 2 0 3-Phenylpropyl 3-(Pyridin-4-yl- 4-Allylyoxy-3,5- carbonyl)phenyl Dimethoxy- phenyl 2 0 3-Phenylpropyl 3-(Pyridin-4-yl- 3-Benzyloxy-4- carbonyl)phenyl methoxyphenyl 2 0 3-Phenylpropyl 3-(Pyridin-4-yl- 3-Allyloxy-4- carbonyl)phenyl methoxyphenyl 2 0 3-Phenylpropyl 3-(Pyridin-4-yl- 3-[3-Phenyl-(E)- carbonyl)phenyl prop-2-enyl]-4- methoxyphenyl 2 0 3-Phenylpropyl 4-(Pyridin-4-yl- 4-Benzyloxy- carbonyl)phenyl 3,5-Dimethoxy- phenyl 2 0 3-Phenylpropyl 4-(Pyridin-4-yl- 3-Benzyloxy-4- carbonyl)phenyl methoxyphenyl 2 0 3-Phenylpropyl 3-(Pyridin-4-yl- 3,4,5-Tri- carbonyl)phenyl methoxyphenol 2 0 3-Phenylpropyl 3-(Pyridin-4-yl- 3,4-Di- carbonyl)phenyl methoxyphenyl 2 0 3-Phenylpropyl Phenyl 3-Benzyloxy-4- methoxyphenyl 2 0 3-Phenylpropyl Phenyl 4-Benzyloxy- 3,5-Dimethoxy- phenyl 1 0 3-(Pyridin-3- 3-Phenylpropyl tert-Butyl yl)-propyl 2 0 3-(Pyridin-3- 3-(Pyridin-3-yl)- 3,4,5-Tri- yl)-propyl propyl methoxyphenol 1 0 Benzyloxymethyl Benzyloxyphenyl 3,4,5-Tri- methoxyphenol 1 0 3-(Pyridin-3- 3-(Pyridin-3-yl)- 3,4,5-Tri- yl-propyl propyl methoxyphenol 2 0 3-(Pyridin-3- 3-(Pyridin-3-yl)- Isopropyl yl)-propyl propyl 2 0 3-(Pyridin-3- 3-(Pyridin-3-yl)- Thiophen-2-yl yl)- 2 0 3-(Pyridin-3- 3-(Pyridin-3-yl)- 3,4-Methylene- yl)-propyl propyl dioxyphenyl 2 0 3-(Pyridin-3- 3-(Pyridin-3-yl)- 3,4-Methylene- yl)-prop-2-ynyl prop-2-ynyl dioxyphenyl 2 0 3-(Pyridin-3- 3-(Pyridin-3-yl)- 3,4,5-Tri- yl)-prop-2-ynyl prop-2-ynyl methoxyphenol 2 0 3-(Pyridin-2- 3-(Pyridin-2-yl)- 3,4,5-Tri- yl-propyl propyl methoxyphenol 2 0 Isopropyl 3,4,5-Tris-(Pyridin- 3,4,5-Tri- 4-ylmethoxy)phenyl methoxyphenol 2 0 3,4,5-Tris- Isopropyl 3,4,5-Tri- (Pyridin-4- methoxyphenol ylmethoxy)phenyl 2 0 Prop-2-enyl 3,4,5-Tris-(Pyridin- 3,4,5-Tri- 4-ylmethoxy)phenyl methoxyphenol 2 0 3,4,5-Tris- Prop-2-enyl 3,4,5-Tri- (Pyridin-4- methoxyphenol ylmethoxy)phenyl ______________________________________
Claim 12
Dependent Claim 62 words
The compound according to claim 1, wherein, in formula (I), at least one of B or D is independently represented by the formula --(CH 2 ) r --(X)--(CH 2 ) s --Ar 2 , wherein: r is 0-4; s is 0-1; and each X is independently selected from the group consisting of CH 2 , O, S, SO, and SO 2 .
Claim 13
Dependent Claim 21 words
A compound selected from the group consisting of: (S)-1-(2-oxo-2-(3,4,5-trimethoxyphenyl)acetyl)piperidine-2-carboxylic acid-4-pyridin-3-yl-1-(3-pyridin-3-yl-propyl)butyl ester; (R)-1-(2-oxo-2-(3,4,5-trimethoxyphenyl)acetyl)piperidine-2-carboxylic acid-4-pyridin-3-yl-1-(3-pyridin-3-yl-propyl)butyl ester; pharmaceutically acceptable derivatives thereof, and mixtures thereof.
Claim 14
Dependent Claim 21 words
A compound selected from the group consisting of: (S)-1-(2-oxo-2-(3,4,5-trimethoxyphenyl)acetyl)piperidine-2-carboxylic acid-4-pyridin-3-yl-1-(3-pyridin-3-yl-propyl)butyl ester; (R)-1-(2-oxo-2-(3,4,5-trimethoxyphenyl)acetyl)piperidine-2-carboxylic acid-4-pyridin-3-yl-1-(3-pyridin-3-yl-propyl)butyl ester; pharmaceutically acceptable derivatives thereof, and mixtures thereof.
Claim 15
Dependent Claim 53 words
A pharmaceutical composition comprising: a compound selected from: (S)-1-(2-oxo-2-(3,4,5-trimethoxyphenyl)acetyl)piperidine-2-carboxylic acid-4-pyridin-3-yl-1-(3-pyridin-3-yl-propyl)butyl ester; (R)-1-(2-oxo-2-(3,4,5-trimethoxyphenyl)acetyl)piperidine-2-carboxylic acid-4-pyridin-3-yl-1-(3-pyridin-3-yl-propyl)butyl ester; pharmaceutically acceptable derivatives thereof, mixtures thereof, other compounds of formula (II) and other compounds of formula (I), said compound being present in an amount effective to treat or prevent multi-drug resistance; and a pharmaceutically acceptable carrier, adjuvant or vehicle.
Claim 16
Dependent Claim 53 words
A pharmaceutical composition comprising: a compound selected from: (S)-1-(2-oxo-2-(3,4,5-trimethoxyphenyl)acetyl)piperidine-2-carboxylic acid-4-pyridin-3-yl-1-(3-pyridin-3-yl-propyl)butyl ester; (R)-1-(2-oxo-2-(3,4,5-trimethoxyphenyl)acetyl)piperidine-2-carboxylic acid-4-pyridin-3-yl-1-(3-pyridin-3-yl-propyl)butyl ester; pharmaceutically acceptable derivatives thereof, mixtures thereof, other compounds of formula (II) and other compounds of formula (I), said compound being present in an amount effective to treat or prevent multi-drug resistance; and a pharmaceutically acceptable carrier, adjuvant or vehicle.
Claim 17
Dependent Claim 12 words
The pharmaceutical composition according to claim 10, further comprising a chemotherapeutic agent.
Claim 18
Dependent Claim 21 words
The pharmaceutical composition according to claim 10 or 11, further comprising a chemosensitizer other than a compound according to formula (I).
Claim 19
Dependent Claim 55 words
A pharmaceutical composition comprising: a compound selected from: (S)-1-(2-oxo-2-(3,4,5-trimethoxyphenyl)acetyl)piperidine-2-carboxylic acid-4-pyridin-3-yl-1-(3-pyridin-3-yl-propyl)butyl ester; (R)-1-(2-oxo-2-(3,4,5-trimethoxyphenyl)acetyl)piperidine-2-carboxylic acid-4-pyridin-3-yl-1-(3-pyridin-3-yl-propyl)butyl ester; pharmaceutically acceptable derivatives thereof, mixtures thereof, other compounds of formula (II) and other compounds of formula (I), said compound being present in an amount effective to reduce, suppress or prevent an immune response; and a pharmaceutically acceptable carrier, adjuvant or vehicle.
Claim 20
Dependent Claim 55 words
A pharmaceutical composition comprising: a compound selected from: (S)-1-(2-oxo-2-(3,4,5-trimethoxyphenyl)acetyl)piperidine-2-carboxylic acid-4-pyridin-3-yl-1-(3-pyridin-3-yl-propyl)butyl ester; (R)-1-(2-oxo-2-(3,4,5-trimethoxyphenyl)acetyl)piperidine-2-carboxylic acid-4-pyridin-3-yl-1-(3-pyridin-3-yl-propyl)butyl ester; pharmaceutically acceptable derivatives thereof, mixtures thereof, other compounds of formula (II) and other compounds of formula (I), said compound being present in an amount effective to reduce, suppress or prevent an immune response; and a pharmaceutically acceptable carrier, adjuvant or vehicle.
Claim 21
Dependent Claim 25 words
The pharmaceutical composition according to claim 13, further comprising an immunosuppressant selected from the group consisting of cyclosporin A, rapamycin, FK-506, 15-deoxyspergualin, OKT3 and azathioprine.
Claim 22
Dependent Claim 23 words
The pharmaceutical composition according to claim 13 or 14, further comprising an immunosuppressant selected from the group consisting of micophenolic acid and brequinar.
Claim 23
Dependent Claim 13 words
The pharmaceutical composition according to claim 13 or 14, further comprising a steroid.
Claim 24
Independent Claim 649 words
A method for treating or preventing multi-drug resistance in a patient comprising the step of administering to said patient a pharmaceutical composition comprising: a compound in an amount effective to treat or prevent said multi-drug resistance; and a pharmaceutically acceptable carrier, adjuvant or vehicle; said compound being a compound of formula (I): ##STR23## wherein: A is CH 2 , oxygen, NH or N--(C1-C4 alkyl); B and D are independently: (i) hydrogen, Ar 1 , (C1-C10)-straight or branched alkyl, (C2-C10)-straight or branched alkenyl or alkynyl, (C5-C7)-cycloalkyl substituted (C1-C6)-straight or branched alkyl, (C2-C6)-straight or branched alkenyl or alkynyl, (C5-C7)-cycloalkenyl substituted (C1-C6)-straight or branched alkyl, (C2-C6)-straight or branched alkenyl or alkynyl, or Ar 1 substituted (C1-C6)-straight or branched alkyl, (C2-C6)-straight or branched alkenyl or alkynyl wherein, in each case, any one of the CH 2 groups of said alkyl, alkenyl or alkynyl chains may be optionally replaced by a heteroatom selected from the group consisting of O, S, SO, SO 2 , N, and NR, wherein R is selected from the group consisting of hydrogen, (C1-C4)-straight or branched alkyl, (C2-C4)-straight or branched alkenyl or alkynyl, and (C1-C4) bridging alkyl wherein a bridge is formed between the nitrogen and a carbon atom of said heteroatom-containing chain to form a ring, and wherein said ring is optionally fused to an Ar 1 group; or ##STR24## (ii) wherein Q is hydrogen, (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl or alkynyl; wherein T is Ar 1 or substituted 5-7 membered cycloalkyl with substituents at positions 3 and 4 which are independently selected from the group consisting of oxo, hydrogen, hydroxyl, O--(C1-C4)-alkyl, and O--(C2-C4)-alkenyl; wherein Ar 1 is a carboxylic aromatic group selected from the group consisting of phenyl, 1-naphthyl, 2-naphthyl, indenyl, azulenyl, fluorenyl, and anthracenyl; or a heterocyclic aromatic group selected from the group consisting of 2-furyl, 3-furyl, 2-thienyl, 3-thienyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, pyrrolyl, oxazolyl, thiazolyl, imidazolyl, pyrazolyl, isoxazolyl, isothiazolyl, 1,2,3-oxadiazolyl, 1,2,3-triazolyl, 1,3,4-thiadiazolyl, pyridazinyl, pyrimidinyl, pyrazinyl, 1,3,5-triazinyl, 1,3,5-trithianyl, indolizinyl, indolyl, isoindolyl, 3H-indolyl, indolinyl, benzo[b]furanyl, benzo[b]thiophenyl, 1H-indazolyl, benzimidazolyl, benzthiazolyl, purinyl, 4H-quinolizinyl, quinolinyl, isoquinolinyl, cinnolinyl, phthalazinyl, quinazolinyl, quinoxalinyl, 1,8-naphthyridinyl, pteridinyl, carbazolyl, acridinyl, phenazinyl, phenothiazinyl, and phenoxazinyl; wherein any occurrence of Ar 1 may contain one to three substituents which are independently selected from the group consisting of hydrogen, halogen, hydroxyl, hydroxymethyl, nitro, trifluoromethyl, trifluoromethoxy, (C1-C6)-straight or branched alkyl, (C2-C6)-straight or branched alkenyl, O--[(C1-C4)-straight or branched alkyl], O--[(C2-C4)-straight or branched alkenyl], O-benzyl, O-phenyl, 1,2-methylenedioxy, amino, carboxyl, N-[(C1-C5)-straight or branched alkyl or (C2-C5)-straight or branched alkenyl)carboxamides, N,N-di-[(C1-C5)-straight or branched alkyl or (C2-C5)-straight or branched alkenyl)]carboxamides, N-morpholinocarboxamide, N-benzylcarboxamide, N-thiomorpholinocarboxamide, N-picolinoylcarboxamide, O--X, CH 2 --(CH 2 ) q --X, O--(CH 2 ) q --X, (CH 2 ) q --O--X, and CH═CH--X; wherein X is 4-methoxyphenyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, pyrazyl, quinolyl, 3,5-dimethylisoxazoyl, isoxazoyl, 2-methylthiazoyl, thiazoyl, 2-thienyl, 3-thienyl, or pyrimidyl; and q is 0-2; L is U; M is either oxygen or CH--U; provided that if L is hydrogen, then M is CH--U or if M is oxygen, then L is not hydrogen; wherein U is hydrogen, O--[(C1-C4)-straight or branched alkyl] or O--[(C2-C4)straight or branched alkenyl], (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl, (C5-C7)-cycloalkyl or (C5-C7)-cycloalkenyl substituted with (C1-C4)-straight or branched alkyl or (C2-C4)-straight or branched alkenyl, [(C1-C4)-alkyl or (C2-C4)-alkenyl]-Y or Y; wherein Y is selected from the group consisting of phenyl, 1-naphthyl, 2-naphthyl, indenyl, azulenyl, fluorenyl, anthracenyl, 2-pyrrolinyl, 3-pyrrolinyl, pyrolidinyl, 1,3-dioxolyl, 2-imidazolinyl, imidazolidinyl, 2H-pyranyl, 4H-pyranyl, piperidyl, 1,4-dioxanyl, morpholinyl, 1,4-dithianyl, thiomorpholinyl, piperazinyl, quinuclidinyl, and heterocyclic aromatic groups as defined above; wherein Y may contain one to three substituents which are independently selected from the group consisting of hydrogen, halogen, hydroxyl, hydroxymethyl, nitro, trifluoromethyl, trifluoromethoxy, (C1-C6)-straight or branched alkyl, (C2-C6)-straight or branched alkenyl, O--[(C1-C4)-straight or branched alkyl], O--[(C2-C4)-straight or branched alkenyl], O-benzyl, O-phenyl, 1,2-methylenedioxy, amino, and carboxyl; J and K are taken together with the N and C atoms to which they are respectively attached to form a 5-7 membered heterocyclic ring containing only one N atom; and m is 0-3.
Claim 25
Independent Claim 649 words
A method for treating or preventing multi-drug resistance in a patient comprising the step of administering to said patient a pharmaceutical composition comprising: a compound in an amount effective to treat or prevent said multi-drug resistance; and a pharmaceutically acceptable carrier, adjuvant or vehicle; said compound being a compound of formula (I): ##STR23## wherein: A is CH 2 , oxygen, NH or N--(C1-C4 alkyl); B and D are independently: (i) hydrogen, Ar 1 , (C1-C10)-straight or branched alkyl, (C2-C10)-straight or branched alkenyl or alkynyl, (C5-C7)-cycloalkyl substituted (C1-C6)-straight or branched alkyl, (C2-C6)-straight or branched alkenyl or alkynyl, (C5-C7)-cycloalkenyl substituted (C1-C6)-straight or branched alkyl, (C2-C6)-straight or branched alkenyl or alkynyl, or Ar 1 substituted (C1-C6)-straight or branched alkyl, (C2-C6)-straight or branched alkenyl or alkynyl wherein, in each case, any one of the CH 2 groups of said alkyl, alkenyl or alkynyl chains may be optionally replaced by a heteroatom selected from the group consisting of O, S, SO, SO 2 , N, and NR, wherein R is selected from the group consisting of hydrogen, (C1-C4)-straight or branched alkyl, (C2-C4)-straight or branched alkenyl or alkynyl, and (C1-C4) bridging alkyl wherein a bridge is formed between the nitrogen and a carbon atom of said heteroatom-containing chain to form a ring, and wherein said ring is optionally fused to an Ar 1 group; or ##STR24## (ii) wherein Q is hydrogen, (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl or alkynyl; wherein T is Ar 1 or substituted 5-7 membered cycloalkyl with substituents at positions 3 and 4 which are independently selected from the group consisting of oxo, hydrogen, hydroxyl, O--(C1-C4)-alkyl, and O--(C2-C4)-alkenyl; wherein Ar 1 is a carboxylic aromatic group selected from the group consisting of phenyl, 1-naphthyl, 2-naphthyl, indenyl, azulenyl, fluorenyl, and anthracenyl; or a heterocyclic aromatic group selected from the group consisting of 2-furyl, 3-furyl, 2-thienyl, 3-thienyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, pyrrolyl, oxazolyl, thiazolyl, imidazolyl, pyrazolyl, isoxazolyl, isothiazolyl, 1,2,3-oxadiazolyl, 1,2,3-triazolyl, 1,3,4-thiadiazolyl, pyridazinyl, pyrimidinyl, pyrazinyl, 1,3,5-triazinyl, 1,3,5-trithianyl, indolizinyl, indolyl, isoindolyl, 3H-indolyl, indolinyl, benzo[b]furanyl, benzo[b]thiophenyl, 1H-indazolyl, benzimidazolyl, benzthiazolyl, purinyl, 4H-quinolizinyl, quinolinyl, isoquinolinyl, cinnolinyl, phthalazinyl, quinazolinyl, quinoxalinyl, 1,8-naphthyridinyl, pteridinyl, carbazolyl, acridinyl, phenazinyl, phenothiazinyl, and phenoxazinyl; wherein any occurrence of Ar 1 may contain one to three substituents which are independently selected from the group consisting of hydrogen, halogen, hydroxyl, hydroxymethyl, nitro, trifluoromethyl, trifluoromethoxy, (C1-C6)-straight or branched alkyl, (C2-C6)-straight or branched alkenyl, O--[(C1-C4)-straight or branched alkyl], O--[(C2-C4)-straight or branched alkenyl], O-benzyl, O-phenyl, 1,2-methylenedioxy, amino, carboxyl, N-[(C1-C5)-straight or branched alkyl or (C2-C5)-straight or branched alkenyl)carboxamides, N,N-di-[(C1-C5)-straight or branched alkyl or (C2-C5)-straight or branched alkenyl)]carboxamides, N-morpholinocarboxamide, N-benzylcarboxamide, N-thiomorpholinocarboxamide, N-picolinoylcarboxamide, O--X, CH 2 --(CH 2 ) q --X, O--(CH 2 ) q --X, (CH 2 ) q --O--X, and CH═CH--X; wherein X is 4-methoxyphenyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, pyrazyl, quinolyl, 3,5-dimethylisoxazoyl, isoxazoyl, 2-methylthiazoyl, thiazoyl, 2-thienyl, 3-thienyl, or pyrimidyl; and q is 0-2; L is U; M is either oxygen or CH--U; provided that if L is hydrogen, then M is CH--U or if M is oxygen, then L is not hydrogen; wherein U is hydrogen, O--[(C1-C4)-straight or branched alkyl] or O--[(C2-C4)straight or branched alkenyl], (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl, (C5-C7)-cycloalkyl or (C5-C7)-cycloalkenyl substituted with (C1-C4)-straight or branched alkyl or (C2-C4)-straight or branched alkenyl, [(C1-C4)-alkyl or (C2-C4)-alkenyl]-Y or Y; wherein Y is selected from the group consisting of phenyl, 1-naphthyl, 2-naphthyl, indenyl, azulenyl, fluorenyl, anthracenyl, 2-pyrrolinyl, 3-pyrrolinyl, pyrolidinyl, 1,3-dioxolyl, 2-imidazolinyl, imidazolidinyl, 2H-pyranyl, 4H-pyranyl, piperidyl, 1,4-dioxanyl, morpholinyl, 1,4-dithianyl, thiomorpholinyl, piperazinyl, quinuclidinyl, and heterocyclic aromatic groups as defined above; wherein Y may contain one to three substituents which are independently selected from the group consisting of hydrogen, halogen, hydroxyl, hydroxymethyl, nitro, trifluoromethyl, trifluoromethoxy, (C1-C6)-straight or branched alkyl, (C2-C6)-straight or branched alkenyl, O--[(C1-C4)-straight or branched alkyl], O--[(C2-C4)-straight or branched alkenyl], O-benzyl, O-phenyl, 1,2-methylenedioxy, amino, and carboxyl; J and K are taken together with the N and C atoms to which they are respectively attached to form a 5-7 membered heterocyclic ring containing only one N atom; and m is 0-3.
Claim 26
Independent Claim 580 words
A method for treating or preventing multi-drug resistance in a patient comprising the step of administering to said patient a pharmaceutical composition comprising: a compound in an amount effective to treat or prevent said multi-drug resistance; and a pharmaceutically acceptable carrier, adjuvant or vehicle; said compound being a compound of formula (I): ##STR25## wherein: A is CH 2 , oxygen, NH or N--(C1-C4 alkyl); B and D are independently (i) Ar 1 , (C1-C10)-straight or branched alkyl, (C2-C10)-straight or branched alkenyl or alkynyl, (C5-C7)-cycloalkyl-substituted (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl or alkynyl, (C5-C7)-cycloalkenyl-substituted (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl or alkynyl, or Ar 1 -substituted (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl or alkynyl wherein, in each case, any one of the CH 2 groups of said alkyl, alkenyl or alkynyl chains may be optionally replaced by a heteroatom selected from the group consisting of O, S, SO, SO 2 ; or ##STR26## (ii) wherein Q is hydrogen, (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl or alkynyl; wherein T is Ar 1 or substituted 5-7 membered cycloalkyl with substitutents at positions 3 and 4 which are independently selected from the group consisting of oxo, hydrogen, hydroxyl, O--(C1-C4)-alkyl or O--(C2-C4)-alkenyl; wherein Ar 1 is a carboxylic aromatic group selected from the group consisting of phenyl, 1-naphthyl, 2-naphthyl, indenyl, azulenyl, fluorenyl, and anthracenyl; or a heterocyclic aromatic group selected from the group consisting of 2-furyl, 3-furyl, 2-thienyl, 3-thienyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, pyrrolyl, oxazolyl, thiazolyl, imidazolyl, pyrazolyl, 2-pyrazolinyl, pyrazolidinyl, isoxazolyl, isothiazolyl, 1,2,3-oxadiazolyl, 1,2,3-triazolyl, 1,3,4-thiadiazolyl, pyridazinyl, pyrimidinyl, pyrazinyl, 1,3,5-triazinyl, 1,3,5-trithianyl, indolizinyl, indolyl, isoindolyl, 3H-indolyl, indolinyl, benzo[b]furanyl, benzo[b]thiophenyl, 1H-indazolyl, benzimidazolyl, benzthiazolyl, purinyl, 4H-quinolizinyl, quinolinyl, isoquinolinyl, cinnolinyl, phthalazinyl, quinazolinyl, quinoxalinyl, 1,8-naphthyridinyl, pteridinyl, carbazolyl, acridinyl, phenazinyl, phenothiazinyl, and phenoxazinyl; wherein any occurrence of Ar 1 may contain one to three substituents which are independently selected from the group consisting of hydrogen, halogen, hydroxyl, nitro, trifluoromethyl, trifluoromethoxy, (C1-C6)-straight or branched alkyl, (C2-C6)-straight or branched alkenyl, O--((C1-C4)-straight or branched alkyl), O--((C2-C4)-straight or branched alkenyl), O-benzyl, O-phenyl, 1,2-methylenedioxy, amino, carboxyl, N-((C1-C5)-straight or branched alkyl or (C2-C5)-straight or branched alkenyl)carboxamides, N,N-di-((C1-C5)-straight or branched alkyl or (C2-C5)-straight or branched alkenyl)carboxamides, N-morpholinocarboxamide, N-benzylcarboxamide, N-thiomorpholinocarboxamide, N-picolinoylcarboxamide, O--X, CH 2 --(CH 2 ) q --X, O--(CH 2 ) q --X, (CH 2 ) q --O--X, and CH═CH--X; wherein X is 4-methoxyphenyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, pyrazyl, quinolyl, 3,5-dimethylisoxazoyl, isoxazoyl, 2-methylthiazoyl, thiazoyl, 2-thienyl, 3-thienyl, or pyrimidyl; and q is 0-2; L is U; M is either oxygen or CH--U; provided that if L is hydrogen, then M is CH--U or if M is oxygen, then L is not hydrogen; wherein U is hydrogen, O--((C1-C4)-straight or branched alkyl) or O--((C2-C4)straight or branched alkenyl), (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl, (C5-C7)-cycloalkyl or (C5-C7)-cycloalkenyl substituted with (C1-C4)-straight or branched alkyl or (C2-C4)-straight or branched alkenyl, [(C1-C4)-alkyl or (C2-C4)-alkenyl]-Y or Y; wherein Y is a carboxylic aromatic group selected from the group consisting of phenyl, 1-naphthyl, 2-naphthyl, indenyl, azulenyl, fluorenyl, anthracenyl; or a heterocyclic aromatic group as defined above; wherein Y may contain one to three substituents which are independently selected from the group consisting of hydrogen, halogen, hydroxyl, nitro, trifluoromethyl, trifluoromethoxy, (C1-C6)-straight or branched alkyl, (C2-C6)-straight or branched alkenyl, O--((C1-C4)-straight or branched alkyl), O--((C2-C4)-straight or branched alkenyl), O-benzyl, O-phenyl, 1,2-methylenedioxy, amino, and carboxyl; J and K are taken together with the N and C atoms to which they are respectively attached to form a 5-7 membered heterocyclic ring containing only one N atom; and m is 0-3.
Claim 27
Independent Claim 580 words
A method for treating or preventing multi-drug resistance in a patient comprising the step of administering to said patient a pharmaceutical composition comprising: a compound in an amount effective to treat or prevent said multi-drug resistance; and a pharmaceutically acceptable carrier, adjuvant or vehicle; said compound being a compound of formula (I): ##STR25## wherein: A is CH 2 , oxygen, NH or N--(C1-C4 alkyl); B and D are independently (i) Ar 1 , (C1-C10)-straight or branched alkyl, (C2-C10)-straight or branched alkenyl or alkynyl, (C5-C7)-cycloalkyl-substituted (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl or alkynyl, (C5-C7)-cycloalkenyl-substituted (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl or alkynyl, or Ar 1 -substituted (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl or alkynyl wherein, in each case, any one of the CH 2 groups of said alkyl, alkenyl or alkynyl chains may be optionally replaced by a heteroatom selected from the group consisting of O, S, SO, SO 2 ; or ##STR26## (ii) wherein Q is hydrogen, (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl or alkynyl; wherein T is Ar 1 or substituted 5-7 membered cycloalkyl with substitutents at positions 3 and 4 which are independently selected from the group consisting of oxo, hydrogen, hydroxyl, O--(C1-C4)-alkyl or O--(C2-C4)-alkenyl; wherein Ar 1 is a carboxylic aromatic group selected from the group consisting of phenyl, 1-naphthyl, 2-naphthyl, indenyl, azulenyl, fluorenyl, and anthracenyl; or a heterocyclic aromatic group selected from the group consisting of 2-furyl, 3-furyl, 2-thienyl, 3-thienyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, pyrrolyl, oxazolyl, thiazolyl, imidazolyl, pyrazolyl, 2-pyrazolinyl, pyrazolidinyl, isoxazolyl, isothiazolyl, 1,2,3-oxadiazolyl, 1,2,3-triazolyl, 1,3,4-thiadiazolyl, pyridazinyl, pyrimidinyl, pyrazinyl, 1,3,5-triazinyl, 1,3,5-trithianyl, indolizinyl, indolyl, isoindolyl, 3H-indolyl, indolinyl, benzo[b]furanyl, benzo[b]thiophenyl, 1H-indazolyl, benzimidazolyl, benzthiazolyl, purinyl, 4H-quinolizinyl, quinolinyl, isoquinolinyl, cinnolinyl, phthalazinyl, quinazolinyl, quinoxalinyl, 1,8-naphthyridinyl, pteridinyl, carbazolyl, acridinyl, phenazinyl, phenothiazinyl, and phenoxazinyl; wherein any occurrence of Ar 1 may contain one to three substituents which are independently selected from the group consisting of hydrogen, halogen, hydroxyl, nitro, trifluoromethyl, trifluoromethoxy, (C1-C6)-straight or branched alkyl, (C2-C6)-straight or branched alkenyl, O--((C1-C4)-straight or branched alkyl), O--((C2-C4)-straight or branched alkenyl), O-benzyl, O-phenyl, 1,2-methylenedioxy, amino, carboxyl, N-((C1-C5)-straight or branched alkyl or (C2-C5)-straight or branched alkenyl)carboxamides, N,N-di-((C1-C5)-straight or branched alkyl or (C2-C5)-straight or branched alkenyl)carboxamides, N-morpholinocarboxamide, N-benzylcarboxamide, N-thiomorpholinocarboxamide, N-picolinoylcarboxamide, O--X, CH 2 --(CH 2 ) q --X, O--(CH 2 ) q --X, (CH 2 ) q --O--X, and CH═CH--X; wherein X is 4-methoxyphenyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, pyrazyl, quinolyl, 3,5-dimethylisoxazoyl, isoxazoyl, 2-methylthiazoyl, thiazoyl, 2-thienyl, 3-thienyl, or pyrimidyl; and q is 0-2; L is U; M is either oxygen or CH--U; provided that if L is hydrogen, then M is CH--U or if M is oxygen, then L is not hydrogen; wherein U is hydrogen, O--((C1-C4)-straight or branched alkyl) or O--((C2-C4)straight or branched alkenyl), (C1-C6)-straight or branched alkyl or (C2-C6)-straight or branched alkenyl, (C5-C7)-cycloalkyl or (C5-C7)-cycloalkenyl substituted with (C1-C4)-straight or branched alkyl or (C2-C4)-straight or branched alkenyl, [(C1-C4)-alkyl or (C2-C4)-alkenyl]-Y or Y; wherein Y is a carboxylic aromatic group selected from the group consisting of phenyl, 1-naphthyl, 2-naphthyl, indenyl, azulenyl, fluorenyl, anthracenyl; or a heterocyclic aromatic group as defined above; wherein Y may contain one to three substituents which are independently selected from the group consisting of hydrogen, halogen, hydroxyl, nitro, trifluoromethyl, trifluoromethoxy, (C1-C6)-straight or branched alkyl, (C2-C6)-straight or branched alkenyl, O--((C1-C4)-straight or branched alkyl), O--((C2-C4)-straight or branched alkenyl), O-benzyl, O-phenyl, 1,2-methylenedioxy, amino, and carboxyl; J and K are taken together with the N and C atoms to which they are respectively attached to form a 5-7 membered heterocyclic ring containing only one N atom; and m is 0-3.
Claim 28
Dependent Claim 48 words
The method according to claim 17 or 18, wherein at least one of B or D is independently selected from the group consisting of (C2-C10)-straight or branched alkynyl; (C5-C7)-cycloalkyl substituted (C2-C6)-straight or branched alkynyl; (C5-C7)-cycloalkenyl substituted (C2-C6)-straight or branched alkynyl; and Ar 1 -substituted (C2-C6)-straight or branched alkynyl.
Claim 29
Dependent Claim 117 words
The method according to claim 17 or 18, wherein, at least one of B or D is independently selected from the group consisting of Ar', Ar'-substituted (C1-C6)-straight or branched alkyl, and Ar'-substituted (C2-C6)-straight or branched alkenyl or alkynyl; wherein Ar' is an Ar group substituted with one to three substituents which are independently selected from the group consisting of N-(straight or branched (C1-C5)-alkyl or (C2-C5)-alkenyl) carboxamides, N,N-di-(straight or branched (C1-C5)-alkyl or (C2-C5)-alkenyl)carboxamides, N-morpholinocarboxamide, N-benzylcarboxamide, N-thiomorpholinocarboxamide, N-picolinoylcarboxamide, O--X, CH 2 --(CH 2 ) q --X, O--(CH 2 ) q --X, (CH 2 ) q --O--X, and CH═CH--X; wherein X is 4-methoxyphenyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, pyrazyl, quinolyl, 3,5-dimethylisoxazoyl, isoxazoyl, 2-methylthiazoyl, thiazoyl, 2-thienyl, 3-thienyl, or pyrimidyl; and q is 0-2.
Claim 30
Dependent Claim 99 words
The method according to claim 17, wherein at least one of B or D is independently represented by the formula --(CH 2 ) r --(X)--(CH 2 ) s --Ar 1 , wherein: r is 0-4; s is 0-1; and each X is independently selected from the group consisting of CH 2 , O, S, SO, SO 2 , N, and NR, wherein R is selected from the group consisting of hydrogen, (C1-C4)-straight or branched alkyl, (C2-C4)-straight or branched alkenyl or alkynyl, and (C1-C4) bridging alkyl, wherein a bridge is formed between the nitrogen atom and the Ar 1 group.
Claim 31
Dependent Claim 34 words
The method according to claim 17 or 18, wherein said compound of formula (I) is selected from the group consisting of: (S)-1-(2-oxo-2-(3,4,5-trimethoxyphenyl)acetyl)piperidine-2-carboxylic acid-4-pyridin-3-yl-1-(3-pyridin-3-yl-propyl)butyl ester; (R)-1-(2-oxo-2-(3,4,5-trimethoxyphenyl)acetyl)piperidine-2-carboxylic acid-4-pyridin-3-yl-1-(3-pyridin-3-yl-propyl)butyl ester; pharmaceutically acceptable derivatives thereof, and mixtures thereof.
Claim 32
Dependent Claim 60 words
A method for reducing, suppressing or preventing an immune response in a mammal comprising the step of administering to said mammal a pharmaceutical composition comprising; a compound in an amount effective to reduce, suppress or prevent said immune response; and a pharmaceutically acceptable carrier, adjuvant or vehicle; said compound being a compound of formula (I) as defined in claim 1.
Claim 33
Dependent Claim 31 words
The method according to claim 23, further comprising the step of administering to said mammal an immunosuppressant selected from the group consisting of cyclosporin A, rapamycin, FK-506, 15-deoxyspergualin, OKT3 and azathioprine.
Claim 34
Dependent Claim 17 words
The method according to claim 23, further comprising the step of administering a steroid to said mammal.
Claim 35
Independent Claim 18 words
The method according to any one of claims 19, 18 or 23, wherein the compound is administered orally.
Claim 36
Dependent Claim 23 words
The method according to claim 17 or 18, wherein the compound is not substantially immunosuppressive at the dosage level required to cause chemosensitization.

References Cited (Backward Citations)

US4296113A Cited
US4376124A Cited
US4579840A Cited
EP0172458A2 Cited
US4920218A Cited
US5135915A Cited
EP0384341A2 Cited
EP0457163A1 Cited
WO1992000278A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2000-04-14 2000-10-14 2001-04-15 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2004-04-14 2004-10-14 2005-04-15 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2008-04-14 2008-10-14 2009-04-15 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag